Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Evolution of Guideline Recommendations on Insulin Therapy in Type 2 Diabetes Mellitus Over the Last Two Decades: A Narrative Review

Author(s): Manoj Chadha*, Sunil M. Jain, Rajeev Chawla, Mala Dharmalingam, Tirthankar Chaudhury, P.G. Talwalkar, Sudhir Tripathi, S.K. Singh, Manish Gutch and Arundhati Dasgupta

Volume 19, Issue 8, 2023

Published on: 02 March, 2023

Article ID: e160123212777 Pages: 11

DOI: 10.2174/1573399819666230116150205

Price: $65

Abstract

The prevalence of type 2 diabetes mellitus has been increasing worldwide. As the therapeutic options for type 2 diabetes mellitus have evolved over the last 2 decades, national and global guidelines related to type 2 diabetes mellitus pharmacotherapy issued by various organizations have tended to vary in their recommendations. This narrative review aimed to analyze the key recommendations by major global and national guidelines on the initiation of insulin therapy in patients with type 2 diabetes mellitus over the last 20 years. Strategies for insulin therapy for titration and intensification were also assessed. All guidelines recommend initiation of insulin (basal/ premixed/other formulations) when glycemic targets are not achieved despite lifestyle measures and oral antidiabetic drugs. In the recent decade, early initiation of insulin has been recommended when the glycated hemoglobin levels are >10% or blood glucose levels are ≥300 mg/dL (16.7 mmol/L). Initiation is recommended at a dose of 10 units or 0.1-0.2 U/kg. Titration is advised to achieve the optimal dosage, while intensification is recommended when glycemic targets are not achieved despite titrating to an acceptable level. Glucose monitoring at periodic intervals is recommended for adequate glycemic control. The guidelines further suggest that the choice of insulin should be individualized, considering the clinical status of patients with type 2 diabetes mellitus. The physicians as well as patients should be a part of the decisions made regarding the therapeutic choice of regimen, preparation, and delivery device.

[1]
IDF diabetes atlas. 2021. Available from: https://diabetesatlas.org/regional-factsheets/ [Accessed on 26 Aug 2022].
[2]
Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: Our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes 2016; 9(5): 504-12.
[http://dx.doi.org/10.1161/CIRCOUTCOMES.116.002901] [PMID: 27553599]
[3]
Swinnen SG, Hoekstra JB, DeVries JH. Insulin therapy for type 2 diabetes. Diabetes Care 2009; 32(S2): S253-9.
[http://dx.doi.org/10.2337/dc09-S318] [PMID: 19875560]
[4]
Garg SK, Rewers AH, Akturk HK. Ever-increasing insulin-requiring patients globally. Diabetes Technol Ther 2018; 20(S2): 1-4.
[http://dx.doi.org/10.1089/dia.2018.0101] [PMID: 29873518]
[5]
Khardori R. Type 2 diabetes mellitus guidelines. Available from: https://emedicine.medscape.com/article/117853-guidelines [Accessed on 18 March 2021].
[6]
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43(S1): S98-S110.
[http://dx.doi.org/10.2337/dc20-S009] [PMID: 31862752]
[7]
International diabetes federation. recommendations for managing type 2 diabetes in primary care. 2017. Available from: www.idf.org/managing-type2-diabetes
[8]
Garber AJ, Handelsman Y, Grunberger G, et al. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary. Endocr Pract 2020; 26(1): 107-39.
[http://dx.doi.org/10.4158/CS-2019-0472] [PMID: 32022600]
[9]
National institute of health and care excellence. type 2 diabetes in adults: Management Available from: www.nice.org.uk/guidance/ng28 [Accessed on 2 July 2021].
[10]
Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP 2020.
[11]
Bajaj S. RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017. Int J Diabetes Dev Ctries 2018; 38(S1): 1-115.
[http://dx.doi.org/10.1007/s13410-018-0604-7] [PMID: 29527102]
[12]
Madhu SV, Chawla R, Makkar BM, Ghosh S, Saboo B, Kalra S. RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. Indian J Endocrinol Metab 2020; 24(1): 1-122.
[http://dx.doi.org/10.4103/ijem.IJEM_225_20] [PMID: 32699774]
[13]
Chawla R, Makkar BM, Aggarwal S, et al. RSSDI consensus recommendations on insulin therapy in the management of diabetes. Int J Diabetes Dev Ctries 2019; 39(S2): 43-92.
[http://dx.doi.org/10.1007/s13410-019-00783-6]
[14]
Mustapha FI, Ghani RA, Tan A, Wan Mohamed WMI, Siew Swee WC. A summary of the malaysian clinical practice guidelines: Management of type 2 diabetes mellitus. J ASEAN Fed Endocr Soc 2014; 26: 20.
[15]
Kamaruddin NA. Clinical practice guidelines: Management of type 2 diabetes mellitus. In: Members of Malaysian Clinical Practice Guidelines Development Group. (6th Ed..), 2020. Available from: https://www.moh.gov.my/moh/resources/Penerbitan/CPG/Endocrine/3a.pdf [Accessed 20 May 2021].
[16]
Siew Pheng C, Wan Bebakar WM, Hussein Z. Clinical practice guidelines: Management of type 2 diabetes mellitus. In: Members of Malaysian Clinical Practice Guidelines Development Group. (5th Ed..), 2015. Available from: http://mems.my/wpcontent/uploads/2021/01/CPG_T2DM_6th Edition_2020.pdf [Accessed 20 May 2021].
[17]
American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002; 25(1): 213-29.
[http://dx.doi.org/10.2337/diacare.25.1.213] [PMID: 11772918]
[18]
American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003; 26(S1): s33-50.
[http://dx.doi.org/10.2337/diacare.26.2007.S33] [PMID: 12502618]
[19]
American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2004; 27: S15-35.
[http://dx.doi.org/10.2337/diacare.27.2007.S15]
[20]
American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2005; 28: S4-S36.
[http://dx.doi.org/10.2337/diacare.28.suppl_1.S4]
[21]
American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 2006; 29(S1): 4-42.
[http://dx.doi.org/10.2337/diacare.29.s1.06.s4] [PMID: 16373931]
[22]
Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the american diabetes association and the european association for the study of diabetes. Diabetes Care 2006; 29(8): 1963-72.
[http://dx.doi.org/10.2337/dc06-9912] [PMID: 16873813]
[23]
American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007; 30(S1): S4-S41.
[http://dx.doi.org/10.2337/dc07-S004] [PMID: 17192377]
[24]
American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008; 31: S12-54.
[http://dx.doi.org/10.2337/dc08-S012] [PMID: 18165335]
[25]
American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32(S1): S13-61.
[PMID: 19118286]
[26]
Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care 2009; 32(1): 193-203.
[http://dx.doi.org/10.2337/dc08-9025] [PMID: 18945920]
[27]
American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33(S1): S11-61.
[http://dx.doi.org/10.2337/dc10-S011] [PMID: 20042772]
[28]
American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34(S1): S11-61.
[PMID: 21193625]
[29]
American Diabetes Association. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2012. Diabetes Care 2012; 35(S1): S11-63.
[http://dx.doi.org/10.2337/dc12-s011]
[30]
Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35(6): 1364-79.
[http://dx.doi.org/10.2337/dc12-0413] [PMID: 22517736]
[31]
American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36(S1): S11-66.
[PMID: 23264422]
[32]
American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014; 37(S1): S14-80.
[http://dx.doi.org/10.2337/dc14-S014] [PMID: 24357209]
[33]
American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care 2015; 38: S1-S84.
[34]
American Diabetes Association. Standards of medical care in diabetes-2016. Diabetes Care 2016; 39: S1-S109.
[35]
American Diabetes Association. Standards of medical care in diabetes-2017. Diabetes Care 2017; 40: S1-S132.
[36]
American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2018. Diabetes Care 2018; 41(S1): S73-85.
[http://dx.doi.org/10.2337/dc18-S008] [PMID: 29222379]
[37]
American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2019. Diabetes Care 2019; 42(S1): S90-S102.
[http://dx.doi.org/10.2337/dc19-S009] [PMID: 30559235]
[38]
American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2021. Diabetes Care 2021; 44(S1): S111-24.
[http://dx.doi.org/10.2337/dc21-S009] [PMID: 33298420]
[39]
Rodbard HW, Blonde L, Braithwaite SS, et al. American association of clinical endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(S1): 1-68.
[PMID: 17613449]
[40]
Handelsman Y, Mechanick JI, Blonde L, et al. American association of clinical endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract 2011; 17(S2): 1-53.
[http://dx.doi.org/10.4158/EP.17.S2.1] [PMID: 21474420]
[41]
Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an american association of clinical endocrinologists/american college of endocrinology consensus panel on type 2 diabetes mellitus: An algorithm for glycemic control. Endocr Pract 2009; 15(6): 540-59.
[http://dx.doi.org/10.4158/EP.15.6.540] [PMID: 19858063]
[42]
Handelsman Y, Bloomgarden ZT, Grunberger G, et al. American association of clinical endocrinologists and american college of endocrinology-clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Aace/ace Guidelines 2015; 21: 1-87.
[43]
Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm-2016 executive summary. Endocr Pract 2016; 22(1): 84-113.
[http://dx.doi.org/10.4158/EP151126.CS] [PMID: 26731084]
[44]
Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2017 executive summary. Endocr Pract 2017; 23(2): 207-38.
[http://dx.doi.org/10.4158/EP161682.CS] [PMID: 28095040]
[45]
Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary. Endocr Pract 2018; 24(1): 91-121.
[http://dx.doi.org/10.4158/CS-2017-0153] [PMID: 29368965]
[46]
Sibal L, Home PD. Management of type 2 diabetes: NICE guidelines. Clin Med 2009; 9(4): 353-7.
[http://dx.doi.org/10.7861/clinmedicine.9-4-353] [PMID: 19728510]
[47]
National institute of health and clinical excellence. Type 2 diabetes: The management of type 2 diabetes. 2009. Available from: https://www.nice.org.uk/guidance/ta203/documents/nice-recommends-liraglutide-for-type-2-diabetes-mellitus4 [Accessed on 21 April 2021].
[48]
National institute of health and clinical excellence. Type 2 diabetes in adults: Management. 2015. Available from: www.nice.org.uk/guidance/ng28 [Accessed on 21 April 2021].
[49]
National institute of health and care excellence. surveillance of diabetes 2019. Available from: https://www.nice.org.uk/guidance/ng28/resources/2019-surveillance-of-diabetes-nice-guidelines-ng17-ng18-ng19-and-ng28-pdf-8862045321157
[50]
National Institute of Health and Clinical Excellence. Type 2 diabetes in adults: Management 2020. Available from: https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-management-pdf-1837338615493 [Accessed on 21 April 2021].
[51]
Guidelines RACGP. Diabetes management in general practice. (17th ed.), 2011/12. Available from: https://www.racgp.org.au/download/documents/Guidelines/Diabetes/201107diabetesmanagementingeneralpractice.pdf
[52]
RACGP Guidelines. General practice management of type 2 diabetes 2014-15. Available from: https://www.trmc.net.au/pdf/general-practice-management.pdf [Accessed on 20 May 2021].
[53]
RACGP Guidelines. General practice management of type 2 diabetes 2016-18. Available from: https://www.racgp.org.au/FSDEDEV/media/documents/Clinical%20Resources/Guidelines/Diabetes/General-practice-management-of-type-2-diabetes_1.pdf [Accessed on 20 May 2021].
[54]
RACGP Guidelines. Management of type 2 diabetes: A handbook for general practice. 2020. Available from: https://www.racgp.org.au/clinical-resources/clinical-guidelines/key -racgp-guidelines/view-all-racgp-guidelines/diabetes/introduction [Accessed on 20 May 2021].
[55]
Lipscombe L, Booth G, Butalia S, et al. Pharmacologic glycemic management of type 2 diabetes in adults. Can J Diabetes 2018; 42(S1): S88-S103.
[http://dx.doi.org/10.1016/j.jcjd.2017.10.034] [PMID: 29650116]
[56]
Lipscombe L, Butalia S, Dasgupta K, et al. Pharmacologic glycemic management of type 2 diabetes in adults: 2020 Update. Can J Diabetes 2020; 44(7): 575-91.
[http://dx.doi.org/10.1016/j.jcjd.2020.08.001] [PMID: 32972640]
[57]
International Diabetes Federation. 2011 guideline for management of postmeal glucose in diabetes. 2011. Available from: https://www.idf.org/component/attachments/attachments.html?id=728&task=download [Accessed on 20 May 2021].
[58]
International diabetes federation, 2012 clinical guidelines task force global guideline for type 2 diabetes. 2012. Available from: https://www.iapb.org/wp-content/uploads/Global-Guideline-for-Type-2-Diabetes-IDF-2012.pdf [Accessed on 21 March 2021].
[59]
Dunning T, Sinclair A, Colagiuri S, New IDF. New IDF guideline for managing type 2 diabetes in older people. Diabetes Res Clin Pract 2014; 103(3): 538-40.
[http://dx.doi.org/10.1016/j.diabres.2014.03.005] [PMID: 24731476]
[60]
IDF global guideline for managing older people with type 2 diabetes. 2017. Available from: https://www.researchgate.net/publication/281562373_IDF_global_guideline_for_managing_older_people_with_type_2_diabetes [Accessed on 20 May 2021].
[61]
SEMDSA guidelines for diagnosis and management of type 2 diabetes mellitus for primary health care-2009. JEMDSA 2014; 14(1): 55-8.
[http://dx.doi.org/10.1080/22201009.2009.10872191]
[62]
Amod A, Motala A, Levitt N, et al. The 2012 SEMSDA guideline for the management of type 2 diabetes. JEMSDA 2012; 17: S1-S94.
[http://dx.doi.org/10.1080/22201009.2012.10872287]
[63]
The 2017 SEMDSA Guideline for the Management of Type 2 Diabetes Guideline Committee. JEMDSA 2017; 22: S1-S196.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy